The Basic and Translational Research Conference is a collaborative effort between the European Association for Cancer Research (EACR), the American Association for Cancer Research (AACR), and the Irish Association for Cancer Research (IACR).
This conference brings together leading experts in immunology, drug development, tumour microenvironment, genomics, and epigenetics. It aims to bridge the gap between fundamental scientific discoveries and practical applications in clinical settings. The focus is on presenting the latest breakthroughs in understanding genomics, epigenetics, and molecular pathways related to the development of pre-cancerous and cancerous conditions. Additionally, it explores advancements in how cancer responds to therapy. The scientific programme covers a spectrum from basic research in preclinical models to its application in patients.
Who should attend?
This conference is designed for basic and translational scientists, including both seasoned investigators and trainees at various levels, who have an interest in cancer development and treatment. It is also relevant for clinicians actively engaged in devising new therapeutic approaches.
Date: 27-29 February 2024
Location: Dublin, Ireland